Making Chemotherapy Easier
- 22 March 1990
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 322 (12), 846-848
- https://doi.org/10.1056/nejm199003223221211
Abstract
Cancer chemotherapy is a double-edged sword. Dramatic responses may be accompanied by equally dramatic toxic effects, the most feared of which are nausea and vomiting.1 The public's perception is that severe nausea and vomiting are inevitable with the use of any chemotherapeutic agent. Fortunately, this is not true. The emetogenic potential of chemotherapeutic agents ranges from severe (cisplatin) to virtually nil (bleomycin). Chemotherapy-induced nausea and vomiting may be severe enough, however, to prevent patients from completing curative courses of treatment. The development of effective antiemetic agents has therefore been an ongoing effort.Chemotherapy induces vomiting through a multiafferent neural reflex . . .Keywords
This publication has 12 references indexed in Scilit:
- Comparison of the 5-Hydroxytryptamine3(Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced EmesisNew England Journal of Medicine, 1990
- Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and VomitingNew England Journal of Medicine, 1990
- Dose ranging phase I study of the serotonin antagonist GR38032F for prevention of cisplatin-induced nausea and vomiting.Journal of Clinical Oncology, 1989
- Dose-ranging evaluation of the serotonin antagonist GR-C507/75 (GR38032F) when used as an antiemetic in patients receiving anticancer chemotherapy.Journal of Clinical Oncology, 1988
- Identification and distribution of 5-HT3 receptors in rat brain using radioligand bindingNature, 1987
- 5-Hydroxytryptamine receptor antagonism by metoclopramide and ICS 205–930 in the guinea-pig leads to enhancement of contractions of stomach muscle strips induced by electrical field stimulation and facilitation of gastric emptying in-vivoJournal of Pharmacy and Pharmacology, 1985
- The enteric neural receptor for 5-hydroxytryptamineCellular and Molecular Life Sciences, 1985
- On the receiving end—patient perception of the side-effects of cancer chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1983
- ANTIEMETICS: NEUROTRANSMITTER RECEPTOR BINDING PREDICTS THERAPEUTIC ACTIONSThe Lancet, 1982
- Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and VomitingNew England Journal of Medicine, 1981